IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
+2.37%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$360M
AUM Growth
+$360M
(+9.4%)
Cap. Flow
+$8.2M
Cap. Flow
% of AUM
2.28%
Top 10 Holdings %
Top 10 Hldgs %
35.72%
Holding
175
New
41
Increased
20
Reduced
27
Closed
26
Top Buys
| 1 |
Milestone Pharmaceuticals
MIST
|
$12.8M |
| 2 |
TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
|
$11.2M |
| 3 |
89bio
ETNB
|
$8.73M |
| 4 |
IMAB
I-MAB
IMAB
|
$7.05M |
| 5 |
Immatics
IMTX
|
$6.77M |
Top Sells
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$15.7M |
| 2 |
Kura Oncology
KURA
|
$14M |
| 3 |
BioXcel Therapeutics
BTAI
|
$11.4M |
| 4 |
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
|
$9.46M |
| 5 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$7.79M |
Sector Composition
| 1 | Healthcare | 96.72% |
| 2 | Industrials | 0% |
| 3 | Real Estate | 0% |
